Showing results (1861-1870 of 1,899) with videos related to
Sort By:
Pageof 190
Immunotherapy|April 11, 2026
Pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction cancer: KEYNOTE-859 Q-TWiST analysisLucjan Wyrwicz, Vasiliki Kalampoki, Adriana Valderrama, et al.Immunotherapy|April 22, 2026
Immune checkpoint inhibitors in POLE/POLD1 proofreading-deficient CRC: from molecular basis to clinical practice and future directionsLei Jiang, Zhongxia Yang, Xiaojun LiuImmunotherapy|May 4, 2026
Oncolytic viruses in brain cancer therapy: advances, challenges, and clinical trial outcomesYaser Arjeini, Sara Khalili Dermani, Sanaz Sadeh, et al.Immunotherapy|May 4, 2026
Tarlatamab in relapsed small-cell lung cancer: a DLL3-targeted bispecific T-cell engagerProdromos Koutoukoglou, Giannis MountziosImmunotherapy|June 14, 2026
From blood draw to tumor infiltration: therapeutic variations in CAR-macrophage therapy for solid tumorsMohsen Ghasem Zadeh Soroush, Alieh Mirzaei, Mahan Ranjbar, et al.Immunotherapy|June 15, 2026
Autoimmune encephalitis and axonal polyradiculoneuropathy following therapy with adalimumab and secukinumab: a case report and literature reviewJuan Sebastián Sánchez León, Eurípedes Gomes de Carvalho Neto, Natana Rangel Ribeiro, et al.Immunotherapy|June 15, 2026
Time-dependent prognostic impact of distant metastatic sites in small cell lung cancer: a comparative analysis of pre- and post-immunotherapy erasRashad Ismayilov, Ulkar Ismayilova, Arzu Oguz, et al.Immunotherapy|July 19, 2023
Mirikizumab for the treatment of moderate to severe ulcerative colitisJurij Hanzel, Christopher Ma, Vipul JairathImmunotherapy|July 26, 2023
Boosting the abscopal effect with chemoradiotherapy/immunotherapy combination in metastatic cervical cancer: a case reportWei Zhang, Min Chen, Qingming Xiang, et al.Pageof 190